SABA, Laura
SABA, Laura
SCIENZE CLINICHE E BIOLOGICHE
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
2019-01-01 Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M.
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period.
2012-01-01 Osella G; Ventura M; Ardito A; Allasino B; Termine A; Saba L; Vitetta R; Terzolo M; Angeli A.
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
2018-01-01 Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo*
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines
2009-01-01 Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A.
Differential responses of serum and salivary interleukin-6 to acute strenuous exercise
2005-01-01 MINETTO M; RAINOLDI A; GAZZONI M; TERZOLO M; BORRIONE P; TERMINE A; SABA L; DOVIO A; ANGELI A; PACCOTTI P
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
2017-01-01 Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo
High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption
2006-01-01 A. DOVIO; L. PERAZZOLO; L. SABA; A. TERMINE; M. CAPOBIANCO; A. BERTOLOTTO; A. ANGELI
Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile
2007-01-01 A. DOVIO; B. ALLASINO; E. PALMAS; M. VENTURA; A. PIA; L. SABA; E. AROASIO; M. TERZOLO; A. ANGELI
Influence of the sample collection method on salivary interleukin-6 levels in resting and exercise-stimulated conditions.
2007-01-01 Minetto M.A.; Gazzoni M.; Lanfranco F.; Baldi M.; Saba L.; Pedrola R.; Rainoldi A.
Influence of the sample collection method on salivary interleukin-6 levels in resting and post-exercise conditions
2007-01-01 MINETTO M.A; GAZZONI M; LANFRANCO F; BALDI M; SABA L; PEDROLA R; KOMI P.V; RAINOLDI A
Influenza del metodo di raccolta salivare sui livelli di Interleukina-6 a riposo e dopo esercizio
2007-01-01 Minetto A.; Gazzoni M; Lanfranco F; Baldi M; Saba L; Pedrola R; Rainoldi A
Interleukin-6 response to isokinetic exercise in elite athletes: relationships to adrenocortical function and to mechanical and myoelectric fatigue
2006-01-01 Minetto M.; Rainoldi A; Gazzoni M.; Ganzit G.P.; Saba L.; Paccotti P.
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma
2020-01-01 Germano, Antonina; Rossin, Daniela; Leoni, Valerio; Iaia, Noemi; Saba, Laura; Basile, Vittoria; Puglisi, Soraya; Caccia, Claudio; Poli, Giuseppe; Biasi, Fiorella; Terzolo, Massimo
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma
2020-01-01 Puglisi S.; Calabrese A.; Basile V.; Ceccato F.; Scaroni C.; Altieri B.; Casa S.D.; Loli P.; Pivonello R.; De Martino M.C.; Canu L.; Russo M.; Badalamenti G.; Torlontano M.; Stigliano A.; Ferrau F.; Arnaldi G.; Saba L.; Quirino A.; Perotti P.; Berchialla P.; Terzolo M.
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
2019-01-01 Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M.
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies
2021-01-01 Lo Iacono M.; Puglisi S.; Perotti P.; Saba L.; Petiti J.; Giachino C.; Reimondo G.; Terzolo M.
Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition
2004-01-01 A. DOVIO; V. CARAMELLO; R.G. MASERA; M.L. SARTORI; L. SABA; M. TINIVELLA; P. PROLO; A. TERMINE; P. AVAGNINA; A. ANGELI
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics
2007-01-01 CHIAPPELLI F ;PROLO P ;D CAJULIS K ;ANGELI A ;DOVIO A ;PEROTTI P ;PAUTASSO M ;LUISA SARTORI M ;SABA L ;MUSSINO S ;FRACCALINI T ;FANTO F ;MANFRINI E ;MOCELLINI C ;GABRIELLA ROSSO M ;GRASSO E
Osteoprotegerina e RANKL solubile in relazione al danno osseo e vascolare nella sclerosi sistemica
2008-01-01 R. Carignola; A. Dovio; V. Data; G. Calzolari; B. Allasino; L. Saba; A. Angeli.
Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression
2007-01-01 PROLO P ;CHIAPPELLI F ;ANGELI A ;DOVIO A ;PEROTTI P ;PAUTASSO M ;SARTORI ML ;SABA L ;MUSSINO S ;FRACCALINI T ;FANTÓ F ;MOCELLINI C ;ROSSO MG ;GRASSO E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. | 2019 | Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M. | |
| Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period. | 2012 | Osella G; Ventura M; Ardito A; Allasino B; Termine A; Saba L; Vitetta R; Terzolo M; Angeli A. | |
| CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells | 2018 | Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo* | |
| Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines | 2009 | Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A. | |
| Differential responses of serum and salivary interleukin-6 to acute strenuous exercise | 2005 | MINETTO M; RAINOLDI A; GAZZONI M; TERZOLO M; BORRIONE P; TERMINE A; SABA L; DOVIO A; ANGELI A; PACCOTTI P | |
| Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma | 2017 | Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo | |
| High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption | 2006 | A. DOVIO; L. PERAZZOLO; L. SABA; A. TERMINE; M. CAPOBIANCO; A. BERTOLOTTO; A. ANGELI | |
| Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile | 2007 | A. DOVIO; B. ALLASINO; E. PALMAS; M. VENTURA; A. PIA; L. SABA; E. AROASIO; M. TERZOLO; A. ANGELI | |
| Influence of the sample collection method on salivary interleukin-6 levels in resting and exercise-stimulated conditions. | 2007 | Minetto M.A.; Gazzoni M.; Lanfranco F.; Baldi M.; Saba L.; Pedrola R.; Rainoldi A. | |
| Influence of the sample collection method on salivary interleukin-6 levels in resting and post-exercise conditions | 2007 | MINETTO M.A; GAZZONI M; LANFRANCO F; BALDI M; SABA L; PEDROLA R; KOMI P.V; RAINOLDI A | |
| Influenza del metodo di raccolta salivare sui livelli di Interleukina-6 a riposo e dopo esercizio | 2007 | Minetto A.; Gazzoni M; Lanfranco F; Baldi M; Saba L; Pedrola R; Rainoldi A | |
| Interleukin-6 response to isokinetic exercise in elite athletes: relationships to adrenocortical function and to mechanical and myoelectric fatigue | 2006 | Minetto M.; Rainoldi A; Gazzoni M.; Ganzit G.P.; Saba L.; Paccotti P. | |
| Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma | 2020 | Germano, Antonina; Rossin, Daniela; Leoni, Valerio; Iaia, Noemi; Saba, Laura; Basile, Vittoria; Puglisi, Soraya; Caccia, Claudio; Poli, Giuseppe; Biasi, Fiorella; Terzolo, Massimo | |
| Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma | 2020 | Puglisi S.; Calabrese A.; Basile V.; Ceccato F.; Scaroni C.; Altieri B.; Casa S.D.; Loli P.; Pivonello R.; De Martino M.C.; Canu L.; Russo M.; Badalamenti G.; Torlontano M.; Stigliano A.; Ferrau F.; Arnaldi G.; Saba L.; Quirino A.; Perotti P.; Berchialla P.; Terzolo M. | |
| Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment | 2019 | Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M. | |
| Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies | 2021 | Lo Iacono M.; Puglisi S.; Perotti P.; Saba L.; Petiti J.; Giachino C.; Reimondo G.; Terzolo M. | |
| Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition | 2004 | A. DOVIO; V. CARAMELLO; R.G. MASERA; M.L. SARTORI; L. SABA; M. TINIVELLA; P. PROLO; A. TERMINE; P. AVAGNINA; A. ANGELI | |
| Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics | 2007 | CHIAPPELLI F ;PROLO P ;D CAJULIS K ;ANGELI A ;DOVIO A ;PEROTTI P ;PAUTASSO M ;LUISA SARTORI M ;SABA L ;MUSSINO S ;FRACCALINI T ;FANTO F ;MANFRINI E ;MOCELLINI C ;GABRIELLA ROSSO M ;GRASSO E | |
| Osteoprotegerina e RANKL solubile in relazione al danno osseo e vascolare nella sclerosi sistemica | 2008 | R. Carignola; A. Dovio; V. Data; G. Calzolari; B. Allasino; L. Saba; A. Angeli. | |
| Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression | 2007 | PROLO P ;CHIAPPELLI F ;ANGELI A ;DOVIO A ;PEROTTI P ;PAUTASSO M ;SARTORI ML ;SABA L ;MUSSINO S ;FRACCALINI T ;FANTÓ F ;MOCELLINI C ;ROSSO MG ;GRASSO E |